Globus Medical, Inc.
NYSE:GMEDMedical - Devices
-$2.10 today
- Market cap
- $9.34B
- Beta
- 0.95
- P/E (TTM)
- 17.4
- EPS (TTM)
- $4.33
Volume 1.43M
Average 1.45M
GMED Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Globus Medical, Inc.NYSE: GMED
Common Stock · Q2 FY2026 · quarter ended Jun 2026
Common stock broadly unchanged from a year ago
Common stock stood at $134K at the end of Q2 FY2026, down 0.7% from a year earlier and down 0.7% from the prior quarter. Over 3 fiscal years it compounded at +10.5% a year.
Context
- Common stock amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Common stock increased in 2 of the last 3 fiscal years.
What to watch
Whether common stock keeps falling in the next quarterly balance sheet after a -0.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 135K USD
- Year-over-year change
- -1.5%
- 4-year CAGR
- +7.5%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 135K | -1.5% |
| FY2024 | 2024-12-31 | 137K | +0.7% |
| FY2023 | 2023-12-31 | 136K | +36.0% |
| FY2022 | 2022-12-31 | 100K | -1.0% |
| FY2021 | 2021-12-31 | 101K | — |
Common Stock vs competitors
How GMED compares with its peers on the latest reported figures
- GMED's Jun 2026 common stock of $134K is the 5th highest of the 10 companies compared; the peer median is $84K.
- Its year-over-year change of -0.7% is the lowest of 9, against a peer median of +0.0%.
- Common stock amounts to 0.0% of total assets for GMED, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Dec 2025 | $175M | +0.0% | +0.0% | 1.7% | |
| Jun 2026 | $38M | +0.0% | +0.0% | 0.1% | |
| Mar 2026 | $4.04M | +3.3% | +25.5% | 0.5% | |
| Jun 2026 | $3.2M | +0.0% | +1.1% | 0.0% | |
| Jun 2026 | $134K | -0.7% | +10.5% | 0.0% | |
| Mar 2026 | $84K | +2.4% | +2.1% | 0.0% | |
| Mar 2026 | $16K | +6.7% | +10.9% | 0.0% | |
| Mar 2026 | $6K | +0.0% | +0.0% | 0.0% | |
| Mar 2026 | $4K | +0.0% | +10.1% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding GMED) | $84K | +0.0% | +1.6% | 0.0% | |
Competitors are the stored peer set for GMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 193.07M | 150.47M | 467.29M | 784.44M | 526.16M |
| Short-term Investments | 250.38M | 295.59M | 50.5M | 105.62M | 31.09M |
| Net Receivables | 165.65M | 217.31M | 504.87M | 578.33M | 743.67M |
| Inventory | 237M | 298.98M | 848.14M | 659.23M | 759.28M |
| Other Current Assets | 0 | 21M | 44.58M | 49.64M | 65.43M |
| Total Current Assets | 864.52M | 983.34M | 1.92B | 2.18B | 2.13B |
| Property, Plant & Equipment (Net) | 221.08M | 243.73M | 646.86M | 611.56M | 628.24M |
| Goodwill | 179.71M | 197.47M | 1.43B | 1.43B | 1.44B |
| Intangible Assets | 68.66M | 63.57M | 924.6M | 795.12M | 745.06M |
| Long-term Investments | 562.48M | 495.85M | 75.43M | 66.13M | 71.82M |
| Tax Assets | 24.49M | 48.85M | 10.69M | 94.2M | 218.22M |
| Other Non-current Assets | 36.33M | 43.31M | 78.59M | 75.1M | 78.78M |
| Total Non-current Assets | 1.09B | 1.09B | 3.17B | 3.07B | 3.18B |
| Total Assets | 1.96B | 2.08B | 5.09B | 5.25B | 5.3B |
| Account Payables | 21.96M | 36.1M | 56.67M | 75.12M | 98.85M |
| Short-term Debt | 0 | 0 | 0 | 443.35M | 0 |
| Tax Payables | 7.46M | 11.02M | 27.57M | 44.81M | 4.16M |
| Deferred Revenue | 12.03M | 14.1M | 18.37M | 22.14M | 27.66M |
| Other Current Liabilities | 64.18M | 66.66M | 201.85M | 185.56M | 186.62M |
| Total Current Liabilities | 140.16M | 159.2M | 392.35M | 855.91M | 498.5M |
| Long-term Debt | 0 | 0 | 417.4M | 0 | 103.92M |
| Deferred Tax Liabilities | 4.31M | 1.78M | 84.42M | 23.89M | 23.76M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 71.4M | 65.3M | 102.92M | 111.03M | 103.34M |
| Total Non-current Liabilities | 75.71M | 70.55M | 695.78M | 218.5M | 231.01M |
| Total Liabilities | 215.88M | 229.75M | 1.09B | 1.07B | 729.51M |
| Common Stock | 101K | 100K | 136K | 137K | 135K |
| Retained Earnings | 1.19B | 1.24B | 1.14B | 1.15B | 1.39B |
| Accumulated OCI | (6.77M) | (24.63M) | (10.19M) | (6.86M) | 15.35M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.74B | 1.85B | 4B | 4.18B | 4.57B |
| Total Debt | 0 | 6.01M | 520.4M | 537.19M | 118.66M |
| Net Debt | (193.07M) | (144.46M) | 53.11M | (247.25M) | (407.5M) |
Globus Medical, Inc.
NYSE:GMED
Intrinsic Alpha fair value
Locked
Current Price
$70.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.